T Rowe Valuation

TMED Etf  USD 29.96  0.01  0.03%   
At this time, the entity appears to be undervalued. T Rowe Price has a current Real Value of $32.32 per share. The regular price of the entity is $29.96. Our model measures the value of T Rowe Price from analyzing the entity fundamentals such as Current Valuation of (509.84 K), return on asset of 3.69, and Return On Equity of 8.96 as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
29.96
Please note that T Rowe's price fluctuation is very steady at this time. Calculation of the real value of T Rowe Price is based on 3 months time horizon. Increasing T Rowe's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the TMED etf is determined by what a typical buyer is willing to pay for full or partial control of T Rowe Price. Since T Rowe is currently traded on the exchange, buyers and sellers on that exchange determine the market value of TMED Etf. However, T Rowe's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  29.96 Real  32.32 Hype  29.93 Naive  30.37
The real value of TMED Etf, also known as its intrinsic value, is the underlying worth of T Rowe Price ETF, which is reflected in its stock price. It is based on T Rowe's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of T Rowe's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
32.32
Real Value
33.34
Upside
Estimating the potential upside or downside of T Rowe Price helps investors to forecast how TMED etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of T Rowe more accurately as focusing exclusively on T Rowe's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
27.2928.8730.45
Details
Hype
Prediction
LowEstimatedHigh
28.9129.9330.95
Details
Naive
Forecast
LowNext ValueHigh
29.3530.3731.38
Details

T Rowe Total Value Analysis

T Rowe Price is at this time forecasted to have valuation of (509.84 K) with market capitalization of 978.86 K, debt of 0, and cash on hands of 1.05 M. The negative valuation of T Rowe may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the T Rowe fundamentals.
  Takeover PriceMarket CapDebt ObligationsCash
(509.84 K)
978.86 K
0
1.05 M

T Rowe Investor Information

T Rowe is is formed as Regulated Investment Company in the United States. ETF is managed and operated by State Street Bank and Trust Company. The fund has 107 constituents across multiple sectors and instustries. The fund charges 0.44 percent management fee with a total expences of 0.44 percent of total asset. Based on the measurements of operating efficiency obtained from T Rowe's historical financial statements, T Rowe Price is not in a good financial situation at the present time. It has a very high likelihood of going through financial trouble in January.

T Rowe Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. T Rowe has an asset utilization ratio of 168.89 percent. This indicates that the ETF is making $1.69 for each dollar of assets. An increasing asset utilization means that T Rowe Price is more efficient with each dollar of assets it utilizes for everyday operations.

T Rowe Profitability Analysis

The company reported the previous year's revenue of 5.57 M. Net Income was 234 K with profit before overhead, payroll, taxes, and interest of 1.89 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates T Rowe's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in T Rowe and how it compares across the competition.

About T Rowe Valuation

The etf valuation mechanism determines T Rowe's current worth on a weekly basis. Our valuation model uses a comparative analysis of T Rowe. We calculate exposure to T Rowe's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of T Rowe's related companies.
Trimedyne, Inc. manufactures and sells lasers, and disposable and reusable fiber-optic laser devices for use in the medical field. Trimedyne, Inc. was founded in 1980 and is based in Irvine, California. Trimedyne operates under Medical Devices classification in USA and is traded on BATS Exchange.
When determining whether T Rowe Price is a strong investment it is important to analyze T Rowe's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact T Rowe's future performance. For an informed investment choice regarding TMED Etf, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T Rowe Price. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in consumer price index.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
The market value of T Rowe Price is measured differently than its book value, which is the value of TMED that is recorded on the company's balance sheet. Investors also form their own opinion of T Rowe's value that differs from its market value or its book value, called intrinsic value, which is T Rowe's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T Rowe's market value can be influenced by many factors that don't directly affect T Rowe's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T Rowe's value and its price as these two are different measures arrived at by different means. Investors typically determine if T Rowe is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T Rowe's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.